← Leaderboards
Kirk U Knowlton
University Of California San Diego
$10,237,846
Attributed
$10,237,846
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.5M · FY2005–14$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$25,419,512 · 12
By mechanism
P01$19,489,648 · 6
R01$2,893,619 · 3
T32$2,618,699 · 1
P50$417,546 · 1
P41$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseCardiac MyocytesBaseStructureProgramsGlycoproteinsCardiomyopathiesMolecularTissue /Cell CultureCardiacKnock-OutCardiovascular PhysiologyProtein Protein InteractionMyocardium DisorderAffectNewborn AnimalsCoxsackievirusMicrofilamentsIdiopathic Dilated CardiomyopathyDystrophinHeart FailureHeartMediatingMyocardium
Grant awards (46)
Training In Cardiovascular Physiology & Pharmacology$401,221
T32 · FY2014 · HL · contact PI
Role of mTOR, a Component of the Akt Pathway, in Regulating Cardiac Function$369,575
R01 · FY2014 · HL · contact PI
Training In Cardiovascular Physiology & Pharmacology$457,559
T32 · FY2013 · HL · contact PI
Role of mTOR, a Component of the Akt Pathway, in Regulating Cardiac Function$359,916
R01 · FY2013 · HL · contact PI
Molecular Pathways for Hypertrophy and Cardiomyopathy$2,175,021
P01 · FY2011 · HL · contact PI
Administative Core$310,718
P01 · FY2011 · HL · contact PI
Adhesion Molecules of the Intercalated Disc in Cardiomyopathy$310,717
P01 · FY2011 · HL · contact PI
Training in Cardiovascular Physiology and Pharmacology$165,520
T32 · FY2011 · HL · contact PI
Molecular Pathways for Hypertrophy and Cardiomyopathy$2,175,021
P01 · FY2010 · HL · contact PI
Training in Cardiovascular Physiology and Pharmacology$314,327
T32 · FY2010 · HL · contact PI
Administative Core$310,718
P01 · FY2010 · HL · contact PI
Adhesion Molecules of the Intercalated Disc in Cardiomyopathy$310,717
P01 · FY2010 · HL · contact PI
Molecular Pathways for Hypertrophy and Cardiomyopathy$2,175,021
P01 · FY2009 · HL · contact PI
Training in Cardiovascular Physiology and Pharmacology$437,370
T32 · FY2009 · HL · contact PI
Administative Core$310,718
P01 · FY2009 · HL · contact PI
Adhesion Molecules of the Intercalated Disc in Cardiomyopathy$310,717
P01 · FY2009 · HL · contact PI
Molecular Pathways for Hypertrophy and Cardiomyopathy$2,131,521
P01 · FY2008 · HL · contact PI
Training in Cardiovascular Physiology and Pharmacology$426,146
T32 · FY2008 · HL · contact PI
Adhesion Molecules of the Intercalated Disc in Cardiomyopathy$371,728
P01 · FY2008 · HL · contact PI
Administative Core$76,741
P01 · FY2008 · HL · contact PI
Molecular Pathways for Hypertrophy and Cardiomyopathy$2,175,021
P01 · FY2007 · HL · contact PI
Adhesion Molecules of the Intercalated Disc in Cardiomyopathy$620,756
P01 · FY2007 · HL · contact PI
Training in Cardiovascular Physiology and Pharmacology$416,556
T32 · FY2007 · HL · contact PI
Cardiac SOCS Proteins: A Role in Enterovirus Infection$216,185
R01 · FY2007 · HL · contact PI
Administative Core$51,603
P01 · FY2007 · HL · contact PI
MOLECULAR PATHWAYS FOR HYPERTROPHY AND CARDIOMYOPATHY$2,178,934
P01 · FY2006 · HL · contact PI
Biomechanical Stress Pathways and Cardiomyopathy$536,601
P01 · FY2006 · HL · contact PI
Cardiac SOCS Proteins: A Role in Enterovirus Infection$222,642
R01 · FY2006 · HL · contact PI
MOLECULAR PATHWAYS FOR HYPERTROPHY AND CARDIOMYOPATHY$2,171,127
P01 · FY2005 · HL
Biomechanical Stress Pathways and Cardiomyopathy$522,699
P01 · FY2005 · HL
Cardiac SOCS Proteins: A Role in Enterovirus Infection$228,000
R01 · FY2005 · HL
CORE--MYOCARDIAL CELL BIOLOGY AND VIRAL VECTOR FACILITY$156,949
P01 · FY2005 · HL
Administrative Core$0
P01 · FY2005 · HL
Dystrophin-glycoprotein complex in viral cardiomyopathy$228,000
R01 · FY2004 · HL
Cardiac SOCS Proteins: A Role in Enterovirus Infection$228,000
R01 · FY2004 · HL
Dystrophin-glycoprotein complex in viral cardiomyopathy$228,000
R01 · FY2003 · HL
Dystrophin-glycoprotein complex in viral cardiomyopathy$228,000
R01 · FY2002 · HL
Dystrophin-glyoprotein complex and dilated cardiomyopathy$139,182
P50 · FY2002 · HL
CORE--CELL BIOLOGY AND VIRAL VECTOR FACILITY$106,600
P01 · FY2002 · HL
Dystrophin-glycoprotein complex in viral cardiomyopathy$228,000
R01 · FY2001 · HL
MYOCYTE APOPTOSIS AND A TRANSGENIC HEART FAILURE MODEL$181,264
R01 · FY2001 · HL
Dystrophin-glyoprotein complex and dilated cardiomyopathy$139,182
P50 · FY2001 · HL
PATHOGENESIS OF VIRAL HEART DISEASE$0
P41 · FY2001 · RR
PATHOGENESIS OF VIRAL HEART DISEASE$0
P41 · FY2001 · RR
MYOCYTE APOPTOSIS AND A TRANSGENIC HEART FAILURE MODEL$176,037
R01 · FY2000 · HL
Dystrophin-glyoprotein complex and dilated cardiomyopathy$139,182
P50 · FY2000 · HL